Journals
Bordetella Adenylate Cyclase Toxin Elicits Airway Mucin Secretion through Activation of the cAMP Response Element Binding Protein.
International Journal of Molecular Sciences.
2022,
22(16),
9064,
ISSN: 1422-0067,
PMID: 34445770,
Selective Enhancement of the Cell-Permeabilizing Activity of Adenylate Cyclase Toxin Does Not Increase Virulence of Bordetella pertussis.
International Journal of Molecular Sciences.
2022,
22(21),
11655,
ISSN: 1422-0067,
PMID: 34769101,
Almost half of the RTX domain is dispensable for complement receptor 3 binding and cell-invasive activity of the Bordetella adenylate cyclase toxin.
The Journal of Biological Chemistry.
2022,
297(1),
100833,
ISSN: 0021-9258,
PMID: 34051233,
Different roles of conserved tyrosine residues of the acylated domains in folding and activity of RTX toxins.
Scientific Reports.
2022,
11(1),
19814,
ISSN: 2045-2322,
PMID: 34615931,
Immunoprotective neo-glycoproteins: Chemoenzymatic synthesis of multivalent glycomimetics for inhibition of cancer-related galectin-3.
European Journal of Medicinal Chemistry.
2022,
220,
113500,
ISSN: 0223-5234,
PMID: 33962190,
Lipid binding by the N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA.
The Journal of Biological Chemistry.
2022,
296,
100607,
ISSN: 0021-9258,
PMID: 33789161,
Simultaneous Determination of Antibodies to Pertussis Toxin and Adenylate Cyclase Toxin Improves Serological Diagnosis of Pertussis.
Diagnostics (Basel, Switzerland).
2022,
11(2),
180,
ISSN: 2075-4418,
PMID: 33513780,
Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.
Genome Biology.
2022,
22(1),
109,
ISSN: 1474-7596,
PMID: 33863344,
Quaternized carbon dot-modified graphene oxide for selective cell labelling – controlled nucleus and cytoplasm imaging.
Chemical Communications.
2014,
50(74),
10782-10785,
ISSN: 1359-7345,
PMID: 24983507,
Hypermethylation of CD19 promoter enables antigen-negative escape to CART-19 in vivo and in vitro.
Journal for Immunotherapy of Cancer.
2021,
9(8),
e002352,
ISSN: 2051-1426,
PMID: 34413165,